Dual CD47 and PD-L1 blockade elicits anti-tumor immunity by intratumoral CD8+ T cells

Author(s):

Susan N. Christo, Keely M. McDonald, Thomas N. Burn, Nadia Kurd, Jessica Stanfield, Megan M. Kaneda, Ruth Seelige, Christopher P. Dillon, Timothy S. Fisher, Bas Baaten, Laura K. Mackay

Details:

Clinical and Translational Immunology, Volume 13, Issue 11, 2024-01-01, Article number e70014

Article Link: Click here

Affiliations:

• Pfizer Inc.
• Department of Microbiology & Immunology